Statins Cut Cardiovascular Risk by 30 Percent in Adults Over 70 With No Prior Heart Disease
A major study presented at the European Society of Cardiology Congress 2026 found that daily use of 40 mg of atorvastatin reduced the risk of heart attack, stroke, or cardiovascular death by 30 percent in adults aged 70 and older with no prior history of cardiovascular disease. The findings were also published in the New England Journal of Medicine.
Adults over 70 with no history of heart disease can significantly cut their cardiovascular risk by taking a daily statin, according to a major study presented at the European Society of Cardiology Congress 2026.
The research found that 40 mg of atorvastatin daily reduced the risk of major cardiovascular events, including heart attack, stroke, and cardiovascular death, by 30 percent in this age group. The findings were published simultaneously in the New England Journal of Medicine.
The study is notable because older adults without prior cardiovascular disease have historically been underrepresented in statin trials. Many physicians have been uncertain about whether the benefits of statins extend to this population.
The treatment effectively lowered LDL cholesterol levels in participants. However, researchers noted that it did not demonstrate a clear improvement in disability-free survival, a measure that tracks whether patients remain free of major disability or death.
Cardiologists say the findings add important evidence for a population that is growing rapidly. Adults over 70 face elevated cardiovascular risk simply due to age, and many have multiple risk factors such as high blood pressure, diabetes, or elevated cholesterol.
Doctors caution that statin therapy should be individualized. Side effects, including muscle pain and liver enzyme changes, can affect some patients. Patients should discuss their specific risk profile with their physician before starting or changing any medication.
The European Society of Cardiology Congress 2026 featured several other major cardiovascular findings, including data on exercise programs for atrial fibrillation and new approaches to heart failure management.
